|
|
|
| Webinar: Streamlining Biotherapy QC: Practical Solutions for Protein Analytics & Residual DNA Testing | Biologic therapies are transforming healthcare—but complex QC challenges can slow progress. Join this Thermo Fisher Scientific webinar to uncover common pitfalls in HPLC protein analytics and residual DNA testing, debunk persistent myths, and gain practical strategies to enhance robustness and reproducibility. Learn how proactive QC planning can streamline workflows and accelerate biotherapeutic development. Click here to learn more. |
|
|
FOCUS ON TRANSLATIONAL RESEARCH |
|
|
|
By Erin Harris, Editor-In-Chief | Our recent Cell & Gene Live, Building The Future Of Cancer Immunotherapy Through Allogeneic NK Cell Innovation, featured expert panelists who covered the state of NK cell science, persistence challenges, safety, scalability, and the unique engineering breakthroughs shaping the future of oncology care. | |
|
|
|
|
| Maximize Your Gene Therapy Process With Genetic Analysis | Infographic | Applied Biosystems by Thermo Fisher Scientific, qPCR | Propel your gene therapy research to the forefront of discovery by incorporating genetic analysis into investigations during the development process. Learn about how to accelerate your timeline. |
|
|
|
TRANSLATIONAL RESEARCH SOLUTIONS |
|
|
|
|
| Advancing the Future of Cell & Gene Therapy | This 11-12 November, Cell 2025 unites 1,000+ leading experts across the CGT value chain to solve key challenges, from scalable bioprocessing and regulatory hurdles to accelerating development timelines. Gain practical strategies across cell culture, therapy development, and CGT manufacturing, and hear from world-renowned leaders Bobby Gaspar (CEO, Orchard Therapeutics), Christof Von Kalle, (Director & BIH Chair, Research Clinic Luxemburg), and Dame Molly Stevens (University of Oxford). Register Now |
|
|
| Connect With Cell & Gene: |
|
|
|
